Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Int J Infect Dis. 2013 Jun 10;17(10):e806–e810. doi: 10.1016/j.ijid.2013.04.006

Table 2.

Incidence of severe anemia in the first six months of HAART by baseline anemia status.

Anemia at baseline Children (N=1648) Severe anemia Incidence per 100 child years (95% CI) Hgb at HAART, gd/L median (IQR) Hgb at severe anemia, gd/L median (IQR)
 No anemia 1123 20 3.3 (2.2–5.2) 10.9 (10.3–11.3) 6.6 (5.4–7.1)
 Mild anemia 407 19 9.0 (5.7–14.0) 9.4 (9.0–9.7) 6.3 (4.5–6.9)
 Moderate anemia 118 8 13.3 (6.7–26.6) 8.1 (7.7–8.3) 6.4 (5.5–7.1)

HAART, highly active antiretroviral therapy; Hgb, hemoglobin.

Classification of anemia was based on the US NIH Division of AIDS 2004 toxicity grading table (9).